iRhythm Technologies Inc stock PB Ratio (=56.21) is close to 10-year high of 56.24.
The historical rank and industry rank for iRhythm Technologies's PB Ratio or its related term are showing as below:
IRTC'
s PB Ratio Range Over the Past 10 Years
Min: 4.26 Med: 17.31 Max: 56.88
Current: 56.88
During the past 11 years, iRhythm Technologies's highest PB Ratio was 56.88. The lowest was 4.26. And the median was 17.31.
IRTC's PB Ratio is ranked worse than 99.62% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.205
vs IRTC: 56.88
During the past 12 months, iRhythm Technologies's average Book Value Per Share Growth Rate was -6.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -32.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -12.40% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of iRhythm Technologies was 64.20% per year. The lowest was -32.60% per year. And the median was 11.40% per year.
Back to Basics: PB Ratio
iRhythm Technologies PB Ratio Historical Data
The historical data trend for iRhythm Technologies's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of iRhythm Technologies's PB Ratio
For the Medical Devices subindustry, iRhythm Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Technologies's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where iRhythm Technologies's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
iRhythm Technologies (NAS:IRTC) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
iRhythm Technologies PB Ratio Related Terms
Thank you for viewing the detailed overview of iRhythm Technologies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IRTC has been successfully added to your 